See the DrugPatentWatch profile for Dexycu
Information on coupons and savings programs for Dexycu is not readily available in the provided text.
How can I save money on Dexycu?
Specific details about financial assistance programs or coupons for Dexycu are not mentioned in the provided information. Patients seeking to reduce the cost of Dexycu may need to explore general savings options or contact the manufacturer directly.
What is Dexycu used for?
Dexycu is an ophthalmic solution containing dexamethasone that is used to treat postoperative inflammation and pain following ocular surgery [1]. It is administered as a single intraocular injection into the anterior chamber of the eye [1].
How is Dexycu administered?
Dexycu is given as a single intraocular injection directly into the anterior chamber during ocular surgery [1]. This method of delivery is intended to provide sustained release of the medication [1].
What is the active ingredient in Dexycu?
The active ingredient in Dexycu is dexamethasone, a corticosteroid [1].
What are the potential side effects of Dexycu?
The provided information does not detail the specific side effects associated with Dexycu. However, as a corticosteroid, potential side effects of dexamethasone in ophthalmic use can include increased intraocular pressure and the formation of cataracts with prolonged use.
Who manufactures Dexycu?
Dexycu is manufactured by EyeGate Pharma [1].
How does Dexycu compare to other post-operative eye inflammation treatments?
Dexycu is noted for its single-injection administration following surgery, aiming for sustained drug delivery to manage postoperative inflammation and pain [1]. This contrasts with some traditional methods that may involve multiple drops applied by the patient over time. The sustained release mechanism is a key differentiator [1].
What is the clinical data supporting Dexycu?
Clinical studies have demonstrated Dexycu's efficacy in reducing postoperative inflammation and pain following ocular surgery [1]. The drug's pharmacokinetic profile supports its sustained release properties [1].
What are the regulatory approvals for Dexycu?
Dexycu has received approval from the U.S. Food and Drug Administration (FDA) for its intended use [1].
Sources:
1. https://www.prnewswire.com/news-releases/eyegate-pharma-announces-fda-approval-of-dexycu-dexamethasone-intraocular-suspension-for-ocular-inflammation-and-pain-300784180.html